News

FDA Offers New Resource on Biosimilars for Health Care Providers (copy 1)


 

References

A free continuing education course, FDA Overview of Biosimilar Products, is available to health care providers. The course was designed to help providers strengthen their knowledge and understanding of biosimilars and interchangeable products, which are not the same as generic products.

In February 2015, the FDA approved the first biosimilar in the U.S., and there is growing interest in biosimilars in the pharmaceutical industry. The new course will help health care professionals understand how a biosimilar can be prescribed and dispensed, and how and when an interchangeable product can be substituted for another biological product.

The course is available to health professionals on FDA’s CDERLearn website and can be completed on a tablet for those not at their desktop computer. Click for more information.

Recommended Reading

Rare Disease Community Prepares for Worldwide Observance of Rare Disease Day
MDedge Cardiology
Omnibus Spending Bill Includes Provisions Important to the Rare Disease Community
MDedge Cardiology
FDA Invites Patient Organizations to Organize Public Meetings to Enhance Awareness of Their Needs
MDedge Cardiology
NIH Releases Its Strategic Plan
MDedge Cardiology
NORD Publishes Physician Guides to PNH and aHUS
MDedge Cardiology
Baylor College of Medicine and National Urea Cycle Disorders Foundation Collaborate on Preclinical Research
MDedge Cardiology
STS: Valved conduit shows right ventricular outflow durability
MDedge Cardiology
Elevated cardiovascular risks linked to hidradenitis suppurativa
MDedge Cardiology
MRI assessment of pulmonary vein stenosis predicts outcomes
MDedge Cardiology
EHR Report: How Zika virus reveals the fault in our EHRs
MDedge Cardiology